Clinical Trials
2 trialsNCT03035357 2024-05-03
Neoadjuvant Listeria or Daratumumab in Prostate Cancer
M.D. Anderson Cancer Center
Phase 2 Withdrawn
NCT03177460 2024-05-03
Daratumumab or FMS Inhibitor JNJ-40346527 Before Surgery in Treating Patients With High-Risk, Resectable Localized or Locally Advanced Prostate Cancer
M.D. Anderson Cancer Center
Phase 1 Completed